Newsletter Subject

Trial Suggests Optimal Approach to Unresectable CRC Liver Mets

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Jun 20, 2023 10:51 PM

Email Preheader Text

Daily Headlines Tuesday, June 20, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT T

[MEDPAGE TODAY]( Daily Headlines Tuesday, June 20, 2023 Today's Top Stories for {NAME} [ONCOLOGY/HEMATOLOGY]( [Trial Suggests Optimal Approach to Unresectable CRC Liver Mets]( [MEETING COVERAGE]( [Wide Variation in CGM Settings for Kids With Diabetes Signals Education Gaps]( [CARDIOLOGY]( [Earlier Detection of Cardiac Dysfunction Possible for Young Adult Cancer Survivors]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [New and Emerging Immunotherapeutic Approaches to Advanced Melanoma]( [MEETING COVERAGE]( [PROs Support Practice-Changing RUBY Trial in Endometrial Cancer]( [CARDIOLOGY]( [Colchicine's Rebirth as Cardiovascular Drug Approved by FDA]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [ENDO 2023 Roundup: More Imcivree Data; Statement on Aging; Novel Hypoparathyroid Tx]( CME SPOTLIGHT [Current Evidence and Guidelines for Treatment Selection for Relapsed/Refractory Multiple Myeloma]( [MEETING COVERAGE]( [Kidney Cancer Highlights From ASCO 2023]( [NEUROLOGY]( [AI Accurately Interprets EEGs; Migraine Drugs Go Head-to-Head; A Nod to Oliver Sacks]( [PSYCHIATRY]( [Screen for Depression, Anxiety in Most Adults, USPSTF Says]( CME SPOTLIGHT [Integrating the Latest Evidence to Personalize Care for Patients With Colorectal Cancer]( [PEDIATRICS]( [Most Parents Support Mental Health Screening for Their Kids, Study Shows]( [MEETING COVERAGE]( ['Encouraging' Data on Sacituzumab Govitecan in Endometrial Cancer]( [CARDIOLOGY]( [Neuroprotector Hopeful in Stroke; Late-Pandemic STEMIs; Exercise vs Risky Carotids?]( CME SPOTLIGHT [Guideline Recommendations for Treatment Selection and Sequencing in Relapsed/Refractory Multiple Myeloma]( [MEETING COVERAGE]( [A Look at the Multiple Myeloma Data Leading to Blenrep's Withdrawal]( [SPECIAL REPORTS]( [What's Changed Since HCA's Takeover of Mission Health?]( [OPINION]( [Why Do We Tolerate Our Health Insurance Problem?]( CME SPOTLIGHT [Patient Perspectives in Myelofibrosis Care]( [OPINION]( [Breathing New Life Into 'Body Donors']( [OPINION]( [If It's June, It Must Be ... Intern Week!]( [MEETING COVERAGE]( [Type 2 Diabetes Cases in Kids Still Rising After 'Return to Normal']( CME SPOTLIGHT [Advancing Collaboration Across the Multiple Myeloma Treatment Journey]( [MEETING COVERAGE]( [T-DXd Benefit in Metastatic Breast Cancer Extends to Older Patients]( [CRITICAL CARE]( [Sepsis Outcomes No Different With Prolonged Beta-Lactam Antibiotic]( [ASCO READING ROOM]( [Rajendra Badwe, MBBS, on Use of an Anesthetic to Help Prevent Breast Cancer Metastasis]( [ASCO READING ROOM]( [Improved Survival in Early-Stage Breast Cancer From Peritumoral Infiltration of Local Anesthetic Before Surgery]( # Weekly Survey [Have You Been Harassed Online?]( Doctors and scientists were frequently harassed online -- with doxxing as well as sexist and racist comments -- during the pandemic, [researchers found]([VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-06-20&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.